[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361703-105":59,"doc-detail-361703-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrin-31-is-not-required-for-onset-of-dysplasia-in-genetic-model-of-colon-cancer-but-promotes-motility-of-colon-cancer-cells","Integrin α3β1 Is Not Required for Onset of Dysplasia in Genetic Model of Colon Cancer but Promotes Motility of Colon Cancer Cells","","Colorectal cancer progression is driven by stage-specific mutations and by extracellular-matrix cues transmitted through integrin receptors. Integrin α3β1 shows pro-tumorigenic or tumor-suppressive effects depending on cancer context, prompting stage-resolved investigation. Using a KRAS-mutated colon-specific α3 knockout mouse model, α3β1 loss did not change pre-cancerous dysplasia and suggested functional compensation. In human colorectal cancer cells, siRNA suppression of α3β1 reduced motility and invasion, supporting a pro-migratory role at later stages.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrin-31-is-not-required-for-onset-of-dysplasia-in-genetic-model-of-colon-cancer-but-promotes-motility-of-colon-cancer-cells/361703/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrin-31-is-not-required-for-onset-of-dysplasia-in-genetic-model-of-colon-cancer-but-promotes-motility-of-colon-cancer-cells/361703.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What did the mouse genetic deletion show about α3β1 in early dysplasia?","Question",{"text":112,"@type":113},"Genetic deletion of α3β1 in the colon did not alter dysplasia in KRAS-mutated colorectal cancer-prone mice, and it was accompanied by increased colocalization of α6 integrin with laminin-332.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did α3β1 suppression affect human colorectal cancer cells?",{"text":117,"@type":113},"Suppressing α3β1 with siRNA caused an approximately 40% to 60% reduction in the motility and invasion of human colorectal cancer cells in vitro.",{"name":119,"@type":110,"acceptedAnswer":120},"Why do the authors suggest targeting α3β1 at specific disease stages?",{"text":121,"@type":113},"The findings indicate α3β1 is dispensable for pre-cancerous dysplasia but promotes motility/invasion at later stages when cells invade, so targeting should align with progression stage.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361703,1791163251,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Article  \nIntegrin α3β1 Is Not Required for Onset of Dysplasia in Genetic Model of Colon Cancer but Promotes Motility of Colon Cancer Cells  \nKathryn E. Ottaviano 1, Sita Subbaram 1,2,3, Lei Wu 1, Kiley Stahl 2, Antoinette J. Mastrangelo 2, Hwajeong Lee 4 and C. Michael DiPersio 1,2, *  \nAcademic Editor: Matteo Landriscina  \nReceived: 8 December 2024  \nRevised: 13 January 2025  \nAccepted: 21 January 2025  \nPublished: 23 January 2025  \nCitation: Ottaviano, K.E.; Subbaram, S.; Wu, L.; Stahl, K.; Mastrangelo, A.J.; Lee, H.; DiPersio, C.M. Integrin α3β1 Is Not Required for Onset of Dysplasia in Genetic Model of Colon Cancer but Promotes Motility of Colon Cancer Cells. Cancers 2025, 17, 371. [https://](https://)[ ](https://)[doi.org/10.3390/cancers17030371](doi.org/10.3390/cancers17030371)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Surgery, Albany Medical College, Albany, NY 12208, USA; [ottavik@amc.edu](ottavik@amc.edu) (K.E.O.); [subbarsi@amc.edu](subbarsi@amc.edu) (S.S.); [wul2@amc.edu](wul2@amc.edu) (L.W.)  \n2 Department of Molecular & Cellular Physiology, Albany Medical College, Albany, NY 12208, USA; [kstahl@uri.edu](kstahl@uri.edu) (K.S.); [mastraa1@amc.edu](mastraa1@amc.edu) (A.J.M.)  \n3 Department of Biology, Union College, Schenectady, NY 12308, USA  \n4 Department of Pathology, Albany Medical College, Albany, NY 12208, USA; [leeh5@amc.edu](leeh5@amc.edu)  \n* Correspondence: [dipersm@amc.edu](dipersm@amc.edu); Tel.: +1-518-262-5916  \nSimple Summary: Integrin α3β1 is an extracellular matrix receptor with pro-tumorigenic/prometastatic roles on many tumor/cancer cells, and its expression has been correlated with poor prognosis, indicating its potential value as a therapeutic target and/or prognostic marker. However, α3β1 has also been linked to tumor-suppressive roles in some cancer types/subtypes, and it may even switch from tumor-supportive to cancer-suppressive during disease progression, which highlights the need to investigate this integrin in different cancersand at different stages. In the current study, we assessed roles for α3β1 in colorectal cancer, where its value as a therapeutic target is underexplored. Using a genetic approach to delete α3β1 in a murine model of colorectal cancer, we showed that it is dispensable for pre-cancerous colonic dysplasia. However, using RNAi to suppress α3β1, we showed that it promotes the motility/invasion of human colorectal cancer cells. These findings indicate that α3β1 may be important at specific stages of colorectal cancer progression.  \nAbstract: Background/Objectives: The progression of colorectal cancer through clinically and histopathologically well-defined stages is driven by specific mutations that activate oncogenes or inactivate tumor-suppressor genes. In addition, pre-cancerous/cancer cells respond to cues from the tissue microenvironment that support tumorigenesis and progression, many of which are transmitted through integrin receptors for the extracellular matrix. Integrin α3β1 has pro-tumorigenic/pro-metastatic roles in many cancers, but it also has suppressive roles in some cancers or at specific stages of progression, indicating that its potential value as a therapeutic target cannot be extrapolated across cancer types or stages. In this study, we investigated roles for α3β1 in colorectal cancer using cellular and genetic models that represent different stages. Methods: We generated mice with colon-specific α3 knockout in a tamoxifen-inducible model of KRAS-mutated colorectal cancer to assess the effects of α3β1 ablation on early dysplasia. We also used siRNA to suppress α3β1 in human colorectal cancer cells, then assessed effects on motilit","cbCaioYl5UErj9Wt","https://ap.wps.com/l/cbCaioYl5UErj9Wt","pdf",9430194,18,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What did the mouse genetic deletion show about α3β1 in early dysplasia?\",\"answer\":\"Genetic deletion of α3β1 in the colon did not alter dysplasia in KRAS-mutated colorectal cancer-prone mice, and it was accompanied by increased colocalization of α6 integrin with laminin-332.\"},{\"question\":\"How did α3β1 suppression affect human colorectal cancer cells?\",\"answer\":\"Suppressing α3β1 with siRNA caused an approximately 40% to 60% reduction in the motility and invasion of human colorectal cancer cells in vitro.\"},{\"question\":\"Why do the authors suggest targeting α3β1 at specific disease stages?\",\"answer\":\"The findings indicate α3β1 is dispensable for pre-cancerous dysplasia but promotes motility/invasion at later stages when cells invade, so targeting should align with progression stage.\"}]","Integrin α3β1 Is Not Required for Onset of Dysplasia in Genetic Model of Colon Cancer but Promotes Motility of Colon Cancer Cells | PDF",1790145331,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66389782117235f8cb85dbbfe5e03790.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcceb044a7bdc6870bbff789c85994e0.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f8349f07c3996125eed989c58258b45.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/842d11351f108feddaf603428c86c837.webp",980,1385]